Table 4.
Descriptive statistics and associated P-values for dog gender, age, baseline Bordetella bronchiseptica (Bb)-specific serum IgG, baseline Bb-specific serum IgA and baseline Bb-specific nasal IgA
Variable | Treatment group | ||||||
---|---|---|---|---|---|---|---|
| |||||||
Injectable Bb vaccine | Intranasal Bb vaccine | ||||||
|
|
||||||
Number of dogs | Female | Male | Number of dogs | Female | Male | P-value | |
Gender (male/female) | 77 | 44 | 33 | 67 | 40 | 27 | 0.8 |
| |||||||
Number of dogs | Median | Range | Number of dogs | Median | Range | P-value | |
| |||||||
Age (years) | 77 | 6.5 | 1 to 15 | 67 | 6 | 1 to 13 | 0.85 |
Baseline Bb-specific serum IgG | 77 | 72.1 | 5.5 to 111.1 | 67 | 75.1 | −3.5 to 128.9 | 0.62 |
Baseline Bb-specific serum IgA | 77 | 67 | 0 to 169 | 67 | 63.5 | 0 to 173 | 0.99 |
Baseline Bb-specific nasal IgA | 62 | 66 | 3 to 116 | 58 | 73 | 0 to 137 | 0.41 |